Eric Merola is an internationally award-winning documentary filmmaker. From art student, to career fine artist, then an animator and animation director, and now a documentary filmmaker on a mission. Eric Merola's biggest passion is to investigate scientific innovations and discoveries that conflict with the profit outcomes of the pharmaceutical industry. Very often promising medical scientific innovations and discoveries face more than the challenges of passing the scrutiny of the scientific method, instead they are often marginalized and ignored when they pose to threaten the established structure of this industry. This creates fertile ground for a documentary journalist like Mr. Merola as he helps the public distinguish the truth from the noise.
BURZYNSKI: CANCER SERIOUS BUSINESS
See the internationally award-winning documentary series that started it all. ’Burzynski’ is an internationally award-winning documentary film series that tells the true story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history. Antineoplastons are responsible for curing some of the most incurable forms of terminal cancer. Various cancer survivors are presented in the film who chose these medicines instead of surgery, chemotherapy or radiation – with full disclosure of medical records to support their diagnosis and recovery – as well as systematic (non-anecdotal) FDA-supervised clinical trial data comparing Antineoplastons to other available treatments—which is published within the peer-reviewed medical literature. Watch the 'Extended Edition' of 'Burzynski Part I' instantly for $4.00 (Film 1 hr 58 min | Extras 1 hr 38 min)
SECOND OPINION: LAETRILE AT SLOAN-KETTERING
See the critically-acclaimed insider whistleblower documentary, Eric Merola’s third documentary. Watch now for $5.00 (Film 76 min | Extras 78 min) This insider documentary chronicles the efforts of whistleblower Ralph W. Moss, PhD to expose a major cancer research center's attempt during the 1970s to conceal the true effectiveness of laetrile an experimental, low-cost cancer drug.